Canonical transient receptor potential (TRPC) channels are Ca 2ϩ -permeable, nonselective cation channels that are widely expressed in numerous cell types. Here, we demonstrate a new mechanism of TPRC isofom 5 (TRPC5) regulation, via cAMP signaling via G␣s. Monovalent cation currents in human embryonic kidney-293 cells transfected with TRPC5 were induced by G protein activation with intracellular perfusion of GTP␥S or by muscarinic stimulation. This current could be inhibited by a membrane-permeable analog of cAMP, 8-bromo-cAMP, by isoproterenol, by a constitutively active form of G␣s [G␣s (Q227L)], and by forskolin. These inhibitory effects were blocked by the protein kinase A (PKA) inhibitors, KT-5720 and H-89, as well as by two point mutations at consensus PKA phosphorylation sites on TRPC5 (S794A and S796A). Surface expression of several mutated versions of TRPC5, quantified using surface biotinylation, were not affected by G␣s (Q227L), suggesting that trafficking of this channel does not underlie the regulation we report. This mechanism of inhibition was also found to be important for the closely related channel, TRPC4, in particular for TRPC4␣, although TRPC4␤ was also affected. However, this form of regulation was not found to be involved in TRPC6 and transient receptor potential vanilloid 6 function. In murine intestinal smooth muscle cells, muscarinic stimulation-induced cation currents were mediated by TRPC4 (Ͼ80%) and TRPC6. In murine intestinal smooth muscle cells, 8-bromo-cAMP, adrenaline, and isoproterenol decreased nonselective cation currents activated by muscarinic stimulation or GTP␥S. Together, these results suggest that TRPC5 is directly phosphorylated by Gs/cAMP/PKA at positions S794 and S796. This mechanism may be physiologically important in visceral tissues, where muscarinic receptor and ␤2-adrenergic receptor are involved in the relaxation and contraction of smooth muscles. canonical transient receptor potential isoform 5; nonselective cation channels; protein kinase A CLASSICAL TRANSIENT RECEPTOR potential channels [canonical transient receptor potential (TRPC)] represent receptor-operated, calcium-permeable cation channels or store-operated calcium channels. There are seven TRPC isoforms, and these can be grouped into four subfamilies: TRPC1, TRPC2, TRPC4/5, and TRPC3/6/7. The G␣ q -PLC pathway is thought to be the primary activation pathway for TRPC channels. In particular, diacylglycerol, a downstream metabolite of PLC pathway, is suggested to be an activator of TRPC3/6/7, but not of TRPC4/5. Intracellular calcium (3, 38), lipid metabolites (8), phosphatidylinositol 4,5-bisphosphate (15, 27, 36), CaM (16, 26, 42) , CaMK (31), and myosin light chain kinase (14, 16, 32) are also molecules involved in the activation process. In addition, activation of TRPCs has been suggested to be expressed via exocytosis of this channel (1, 4, 24). For example, TRPC5 activation by epidermal growth factor in developing neurites requires exocytotic insertion of the channels (1). This process is mediated by receptor tyrosine kinases and is relatively slow compared with activation by agonists of G proteincoupled receptor. Protein kinase (PK) C was shown to be involved in the desensitization process of TRPC4/5 (44), and phosphorylation of TRPC3 by the nitric oxide-cGMP-PKG pathway results in deactivation (19).
diacylglycerol, a downstream metabolite of PLC pathway, is suggested to be an activator of TRPC3/6/7, but not of TRPC4/5. Intracellular calcium (3, 38) , lipid metabolites (8) , phosphatidylinositol 4,5-bisphosphate (15, 27, 36) , CaM (16, 26, 42) , CaMK (31) , and myosin light chain kinase (14, 16, 32) are also molecules involved in the activation process. In addition, activation of TRPCs has been suggested to be expressed via exocytosis of this channel (1, 4, 24) . For example, TRPC5 activation by epidermal growth factor in developing neurites requires exocytotic insertion of the channels (1) . This process is mediated by receptor tyrosine kinases and is relatively slow compared with activation by agonists of G proteincoupled receptor. Protein kinase (PK) C was shown to be involved in the desensitization process of TRPC4/5 (44) , and phosphorylation of TRPC3 by the nitric oxide-cGMP-PKG pathway results in deactivation (19) .
TRPC4 and TRPC5 are close homologs, sharing 64% sequence identity, and also sharing many functional characteristics. For example, they are both potentiated by G proteincoupled receptors that couple to G␣ q/11 , and they have similar current-voltage (I-V) relationships. At the cellular level, TRPC4 plays an important role in Ca 2ϩ signaling in endothelial cells (9) and in mediating the increase of 5-hydroxytryptamine 2 receptor-coupled GABA release in thalamic interneurons (23) . TRPC4 knockout mice have defects in acetylcholine-induced vasoregulation and lung microvascular permeability (9, 35) ; however, they are viable, fertile, and exhibit no gross abnormalities (9) . Similarly, TRPC5 knockout mice exhibit no obvious developmental or anatomical defects. They exhibit a reduced anxiety-like (innate fear) phenotype, however, due to reduced responses mediated by group 1 mGluR and cholecystokinin 2 receptors in neurons of the amygdala (28) . In addition, a constitutively active nonselective cation current, which depends on TRPC channels containing the TRPC5 subunit, is present in rat hypocretin/orexin neurons and is responsible for the depolarized and active state of these cells. Finally, insertion of TRPC5 channels contributes to the generation of the prolonged afterdepolarizations following muscarinic stimulation (5) . This altered plasma membrane expression of TRPC5 channels in pyramidal neurons may play an important role in the generation of prolonged neuronal depolarization and bursting during the epileptiform seizure discharges of epilepsy (34) .
cAMP is an important second messenger that executes diverse physiological function in living cells. In particular, cAMP-dependent PKA in primary afferents plays a major role in producing inflammatory hyperalgesia. There are a variety of examples of cAMP-dependent regulation of other transient receptor potentials. For example, phosphorylation of transient receptor potential vanilloid (TRPV) 1 at Ser-116 by PKA regulates desensitization and may be relevant to the regulation of TRPV1 function after tissue injury (2) . In kidney, parathyroid hormone activates the cAMP-PKA signaling cascade, which rapidly phosphorylates threonine-709 of TRPV5, increasing the channel's open probability and promoting Ca 2ϩ reabsorption in the distal nephron (6) . In principal cells of the collecting duct, AVP stimulation of V2 receptors causes translocation of TRPC3 to the apical membrane via stimulation of the adenylate cyclase (AC)/cAMP/PKA signaling cascade (11) . Additionally, cAMP activates TRPC6 via the phosphatidylinositol 3-kinase (PI3K)-PKB-MEK-ERK-1/2 signaling pathway in human embryonic kidney (HEK)-293 cells, a mechanism that may be similar to that which underlies glucagon-induced calcium rises in glomerular mesangeal cells (30) . It has previously been shown that G␣ i and G␣ o increase TRPC4 and TRPC5 currents, whereas G␣ s decreases them (12) . G␣ i and G␣ s are known to regulate intracellular cAMP by regulation of AC. Therefore, here we have investigated the involvement of the cAMP pathway on activation and inactivation of TRPC5 and TRPC4. We show that the G␣ s -cAMP-PKA pathway is involved in the inactivation process through the COOH-terminus of TRPC5 and TRPC4.
MATERIALS AND METHODS
Plasmids and mutagenesis. Plasmids containing human TRPC5 (hTRPC5) were kindly donated by Dr. S. Kaneko. Point mutations in hTRPC5 were introduced using a QuickChange site-directed mutagenesis kit (Stratagene) with appropriate primer sets. Mutant sequences were confirmed by DNA sequencing.
RT-PCR. Total RNA from HEK-293 was extracted using the RNeasy mini kit, catalogue no. 74104 (QIAGEN). One microgram of total RNA was reverse-transcribed with Superscript III, catalog no. 18080-051 (Invitrogen). PCR conditions were as follows: preheating (94°C for 2 min), 32 cycles of denaturation (94°C for 30 s), annealing (50°C for 30 s), extension (72°C for 60 s), and 1 cycle of final extension (72°C for 10 min). Gene-specific primers were designed as follows: forward, 5=-CAGCAAAGGGACGAGGTG-3= and Reverse, 5=-AAGTAATGGCAAAGTAGCG-3=. Fig. 1 . The effect of isoproterenol (ISO) on GTP␥S-activated inward current from human canonical transient receptor potential 5 (hTRPC5)-expressing human embryonic kidney (HEK) cells using the whole cell patch-clamp technique. Slow depolarizations from ϩ100 to Ϫ100 mV were applied from a holding potential of Ϫ60 mV. A: whole cell currents were recorded under the condition of 140 mM intracellular Cs ϩ concentration ([Cs ϩ ]i). When external solution was changed to 140 mM extracellular Cs ϩ concentration ([Cs ϩ ]o) solution, an inward current was activated in the presence of internal 0.2 mM GTP␥S. B: summary graph of TRPC5 current. At Ϫ60 mV, the amplitude of Cs-induced inward current was constant. C: current (I)-voltage (V) relationships showed a typical doubly rectifying shape. D: pretreatment of ISO inhibited an inward current in the presence of internal 0.2 mM GTP␥S. The effect of ISO was irreversible. E: summary graph of canonical transient receptor potential 5 (TRPC5) current. At Ϫ60 mV, the amplitude of Cs induced an inward current, which was constant. At Ϫ60 mV, the amplitude of Cs induced an inward current in the presence of ISO, which was smaller than that of control. **P Ͻ 0.01. F: I-V relationships showed a typical doubly rectifying shape. PRO, propranolol; Wash, washout.
Cell culture and transient transfection. HEK-293 cells (American Type Culture Collection) were maintained according to the supplier's recommendations. For transient transfection, cells were seeded in 12-well plates. The next day, 0.5-2 g/well of the pcDNA vector containing the cDNA of hTRPC5, or point mutants of hTRPC5, were transfected into cells using FuGENE 6 transfection reagent (Roche Molecular Biochemicals), according to the manufacturer's protocol. cDNAs for hTRPC4␣-enhanced green fluorescent protein (EGFP), mouse TRPC6-EGFP, YFP-tagged human TRPV6 (pEYFP-N1) were also transfected in the same way. cDNA for mouse TRPC4␤ was mixed with 50 -100 ng/well of pEGFP-C1 (Clontech) and were transfected in the same way. After 18 -24 h, cells were trypsinized and used for whole cell experiments.
Surface biotinylation. Cells were washed with and suspended in PBS. Suspended cells were incubated in 0.5 mg/ml sulfo-NHS-LCbiotin (Pierce) in PBS for 30 min on ice. Free biotin was quenched by the addition of 100 mM glycine in PBS. Lysates were prepared in lysis buffer by passing 7-10 times through a 26-gauge needle after sonication. Lysates were centrifuged at 13,300 g for 10 min at 4°C, and protein concentration in the supernatants was determined. Forty microliters of a 50% slurry of avidin beads (Pierce) were added to cell lysates (400 g of protein). After incubation for 1 h at RT, beads were washed three times with 0.5% Triton-X-100 in PBS, and proteins were extracted in sample buffer. Collected proteins were then analyzed by Western blot.
Dissociation of single cells from the mouse small intestine. Ileal myocytes were isolated enzymatically from the ileal region of the Institute for Cancer Research mouse. The mice used were treated ethically, according to the Guidelines for the Care and Use of Animals, approved by Pusan National University. Mice of either sex weighing 20 -30 g were anesthetized with carbon dioxide and killed by cervical dislocation. The ileal part of the intestine was excised, and the mucous layer was dissected away from the smooth muscle layer using fine scissors, and then cut into small segments (2-3 mm). Segments were then digested for 25-30 min at 37°C in Ca 2ϩ -free Tyrode solution containing 0.1% collagenase (Worthington type 2), 0.1% dithiothreitol, 0.1% trypsin inhibitor, and 0.2% bovine serum albumin. Single myocytes were dispersed by gentle agitation of the digested segments with a wide-bored glass pipette and kept at 4°C until use. All experiments were carried out within 10 h of harvesting the cells and at room temperature.
Electrophysiology. Whole cell currents were recorded using an Axopatch 200B amplifier (Axon Instruments, Union City, CA). Currents were filtered at 5 kHz (Ϫ3 dB, 4-pole Bessel), digitized using a Digidata 1350 Interface (Axon Instruments), and analyzed using a personal computer equipped with pClamp 9.0 software (Axon Instruments) and Origin software (Microcal origin version 7.0, Microcal, Piscataway, NJ). Patch pipettes were made from borosilicate glass and had resistances of 3-6 M⍀ when filled with standard intracellular solutions. For all whole cell experiments on TRPCs, we used an external bath medium (normal Tyrode solution) of the following composition (in mM): 135 NaCl, 5 KCl, 2 CaCl 2, 1 MgCl2, 10 glucose, and HEPES, with pH adjusted to 7.4 using NaOH. Cs ϩ -rich external solution was made by replacing NaCl and KCl with equimolar CsCl. The pipette solution contained (in mM) 140 CsCl, 10 HEPES, 0.2 Tris-GTP, 0.5 EGTA, and 3 MgATP, with pH adjusted to 7.3 using CsOH. For experiments with TRPV6, the extracellular solution consisted (in mM) of 145 NaCl, 0 or 2 CaCl 2, 10 CsCl, 2.8 KCl, 1 MgCl2, 10 glucose, and 10 HEPES, adjusted to pH 7.2 with NaOH. The divalent-free solution contained (in mM) 145 NaCl, 2.8 KCl, 10 CsCl, 10 glucose, 10 EGTA, and 10 HEPES, adjusted to pH 7.2 with NaOH. The standard internal solution contained (in mM) 145 cesium glutamate, 10 HEPES, 8 NaCl, 1 MgCl 2, and 2 Mg-ATP, adjusted to pH 7.2 with CsOH. I-V curves to investigate TRPV6 function were performed by applying a voltage ramp (from Ϫ100 to ϩ100 mV for 1,500 ms) from a holding potential of 0 mV and of all other TRPCs by applying voltage-ramp pulse (from ϩ100 mV to Ϫ100 mV for 500 ms) from a holding potential of Ϫ60 mV. The calculated junction potential between the pipette and bath solutions used for all cells during sealing was 5 mV (pipette negative), using pClamp 9.0 software (Molecular Devices). No junction potential correction was applied. Experiments were performed at room temperature (18 -22°C). Cells were continuously perfused at a rate of 0.5 ml/min.
Confocal imaging. Confocal imaging was performed to determine the localization of TRPC5. Transfected cells were fixed by incubation with 4% formaldehyde in PBS for 15 min. After being washed in PBS, cells were incubated with 5 g/ml Alexa Fluor 594 wheat germ agglutinin (WGA) and 1 M Hoechst 33342 dye (Invitrogen) for 10 min or for 5 min at room temperature. Confocal images were visualized on an Olympus FV-1000 confocal microscope with a ϫ60 1.35 numerical aperture oil lens. TRPC5 expression was detected based on excitation of a signal with 488-nm wavelength light (from an argon laser). The cell membrane was visualized using WGA, which has an excitation wavelength of 594 nm. Hoechst dye excited with 350-nm light emits blue fluorescence when bound to DNA. Colocalization Fig. 2 . Effect of constitutively active G␣s, G␣s (Q227L), on GTP␥S-activated inward current from hTRPC5-expressing HEK cells using the whole cell patch-clamp technique. Slow depolarizations from ϩ100 to Ϫ100 mV were applied from a holding potential of Ϫ60 mV. A: whole cell currents were recorded under the condition of 140 mM [Cs ϩ ]i. When external solution was changed to 140 mM [Cs ϩ ]o solution, an inward current was activated in the presence of internal 0.2 mM GTP␥S. Cs induced an inward current, which was activated from hTRPC5 and pcDNA3-expressing HEK cells. B: Cs induced an inward current, which was activated from hTRPC5 and G␣s (Q227L)-expressing HEK cells. C: summary graph of TRPC5 current. At Ϫ60 mV, the amplitude of TRPC5 current in the presence of G␣s(Q227L) was smaller than that of control, regardless of GTP␥S. **P Ͻ 0.01. analysis was performed using MetaMorph Software (Molecular Devices).
Statistics. Results are expressed as means Ϯ SE. Results were compared using Student's t-test between two groups, or using ANOVA followed by post hoc test among three groups or more. P Ͻ 0.05 was considered statistically significant. The number of cell recordings is given by n.
RESULTS
Effects of G␣ s signaling on TRPC5 current. Extracellular monovalent cations modulate the activity of TRPC5. For example, 140 mM Cs ϩ enhances channel activities compared with extracellular Na ϩ (7, 13, 21, 37, 43) . Furthermore, inducing TRPC5 currents using Cs ϩ ions applied in the presence of GTP␥S in the whole cell solution has two advantages for studies of TRPC5: 1) this results in a typical electrophysiological signature (doubly rectifying I-V curve); and 2) this minimizes current run-down. Therefore, TRPC5 currents were induced repeatedly by externally applied Cs ϩ in the presence of 0.2 mM GTP␥S applied in the pipette solution (Fig. 1A) . The current (I) to voltage (V) relationship in the presence of 140 mM external Cs ϩ showed the typical doubly rectifying shape (Fig. 1C) , and the second and third Cs ϩ induced currents were of a similar amplitude to the first (Fig. 1, A and B) .
Stimulation of the ␤ 2 -adrenergic receptor increases intracellular cAMP. Therefore, to investigate the effect of cAMP on TRPC5 currents in HEK cells, we applied an agonist of ␤ 2 -adrenergic receptors, isoproterenol (ISO; 300 M). The presence of ␤-adrenergic receptors in the HEK cells used for expression of TRPC5 was confirmed by RT-PCR [Supplemental Fig. S1 (the online version of this article contains supplemental data); see also Ref. 40 for endogenous expression of the ␤-adrenergic receptor in HEK cells]. ISO decreased the TRPC5 current to 47 Ϯ 8% compared with control, an effect that was irreversible (responses following washout of drug were 41 Ϯ 10% of control values) (Fig. 1, D and E) . As endogenous G␣ s has a limited signal duration, we coexpressed the constitutively active form of G␣ s , G␣ s (Q227L). In the presence and absence of 0.2 mM GTP␥S applied via the pipette solution, G␣ s (Q227L) reduced GTP␥S-induced TRPC5 currents to 21 Ϯ 1 and 19 Ϯ 3 pA/pF, respectively (Fig. 2) . These results suggest that G␣ s signaling cascades are involved in regulation of TRPC5. 
Effects of PKA inhibitors on cAMP-induced inhibition of TRPC5.
To investigate the involvement of AC, which acts downstream from G␣ s , we used an activator of AC, forskolin (FSK). FSK reduced TRPC5 current to 63 Ϯ 4% compared with control, in a reversible manner (Fig. 3, A and B) . In addition, a cell-permeable analog of cAMP, 8-bromocAMP (8-Br-cAMP; 100 M) inhibited TRPC5 currents to 26 Ϯ 4% of the control value (Fig. 3, D and E) , an effect that was reversible and concentration dependent (Supplemental Fig. S2) . Carbachol is also able to activate TRPC5 channels in a way that gives the characteristic doubly rectifying I-V relation and is sensitive to 8-Br-cAMP (Supplemental Fig. S3) .
We investigated the involvement in this mechanism of PKA pharmacologically. The PKA inhibitors H-89 (10 M) applied via the patch pipette and KT5270 (1 M) applied in the bath solution both blocked the effects of ISO, FSK, and 8-Br-cAMP (Fig. 4, A and C) . In addition, H89 blocked TRPC5 inhibition induced by constitutively active G␣ s induced (Fig. 4B) .
Effects of mutants on PKA-dependent inhibition of TRPC5. We identified five putative PKA phosphorylation sites in the COOH-terminus of hTRPC5: S732, S794, S796, S821, and S841. We mutated these serine residues to alanine, yielding five TRPC5 mutants: S732A, S794A, S796A, S821A, and S841A. All mutants exhibited the characteristic doubly rectifying I-V relationship (Fig. 5B) . Current densities (in pA/pF) were 33 Ϯ 3 (n ϭ 11), 49 Ϯ 3 (n ϭ 10), 81 Ϯ 13 (n ϭ 11), 17 Ϯ 2 (n ϭ 9), and 3 Ϯ 1 (n ϭ 6) for S732A, S794A, S796A, S821A, and S841A mutants, respectively. Two mutants, S794A and S796A, prevented the effect of G␣ s (Q227L) (Fig.  5A ), suggesting that they are potential sites for PKA-dependent inhibition of TRPC5. A greater effect was seen at S796, suggesting that this may be the primary residue involved in this regulation.
The inhibition of TRPCs by PKA is specific for TRPC5 and TRPC4. Many transient receptor potential channels are modulated by protein kinases, including TRPC5 and TRPC6, which are each inhibited by PKC and PKG. Inhibition of TRPC5 by PKA may suggest a characteristic common across TRPC subfamily members. We, therefore, investigated if the effect of G␣ s (Q227L) is specific for TRPC5. Coexpressed G␣ s (Q227L) did not inhibit TRPC6 or TRPV6 currents (Fig. 5C ). However, G␣ s (Q227L) was able to inhibit both TRPC4␣ and TRPV4␤, which belongs to the same TRPC subfamily as TRPC5. A greater degree of inhibition was seen for TRPC4␣ than for TRPC4␤ (Fig. 5C) .
To investigate if G␣ s (Q227L) exerts its effects via changes to the synthesis or surface expression of TRPC5, we examined the surface expression of GFP-tagged TRPC5 in HEK-293 cells by confocal microscopy. WGA (red) and Hoechst (blue) were used to visualize plasma membrane and the nucleus, respectively. In control cells, dominant fluorescence signals were observed at the cell periphery, as well as the cytoplasm (Fig. 6A) . The fluorescence intensity profiles measured along a line drawn across the cell membrane near the nucleus also confirmed that the areas of high intensity were at the cell periphery in control cells (Fig. 6B) . Distribution of TRPC5 was not decreased by coexpression of G␣ s (Q227L) compared with control cells, however. Next, the effect of G␣ s (Q227L) on surface expression of TRPC5 mutants was quantified using the surface biotinylation. First, the effect of the mutations alone was investigated. Total expression of S821A and S841A mutants was increased compared with WT, whereas the other mutations had no effect. However, surface levels of all TRPC5 mutants were increased compared with WT, suggesting that all of the point mutations have an effect on trafficking of these channels. When G␣ s (Q227L) was coexpressed, total expression of WT and all TRPC5 mutants was increased compared with that of controls. Furthermore, G␣ s (Q227L) did not affect the surface expression of each mutant (Fig. 6C) . These results suggest that TRPC5 can be directly inhibited by PKA Fig. 4 . The effect of PKA inhibitor on GTP␥S-activated inward current from hTRPC5-expressing HEK cells using the whole cell patch-clamp technique. Slow depolarizations from ϩ100 to Ϫ100 mV were applied from a holding potential of Ϫ60 mV. phosphorylation. The regulation of synthesis or surface expression of TRPC5 by G s /cAMP/PKA pathway does not explain the inhibition of TRPC5 by cAMP pathway, considering that only two mutants, S794A and S796A, were not inhibited by constitutively active G␣ s Q227L (Fig. 5A) .
Effect of 8-Br-cAMP on GTP␥S-induced or carbachol-induced inward currents in murine small intestinal smooth muscles.
Whole cell patch-clamp recordings using an internal containing 0.2 mM GTP␥S were made from murine small intestinal smooth muscle cells. Application of 140 mM extracellular Cs ϩ concentration solution at a holding potential of Ϫ60 mV resulted in an inward current, similar to that reported previously (12) . Repetitive application of Cs resulted in a slight run down in amplitude; a second application (delivered 4 min after the first) resulted in a response that was 85 Ϯ 2% of the first (Fig. 7A, top trace) . To investigate the role of cAMP in murine ileal myocytes, we used cell-permeable 8-Br-cAMP. Experiments in which Cs was first applied alone, and then in the presence of 8-Br-cAMP, revealed that 8-Br-cAMP reduced the response to 37.8 Ϯ 3% of the first (n ϭ 5; Fig. 7A , bottom trace, summarized in Fig. 7D ). We also obtained similar results when currents were induced using a physiological agonist, adrenalin (Fig. 7, C and D) . The effect of 8-Br-cAMP was confirmed by observation of carbachol-induced inward currents (Fig. 7, E and F) . In addition, ␤-adrenergic agonist (ISO) showed a similar effect to adrenaline, and its effect was reversed by propranolol.
DISCUSSION
We present the G␣ s -AC-cAMP-PKA pathway as a new inactivation pathway for TRPC5. We have examined pharmacologically every stage of this pathway and demonstrated that cesium-induced currents in HEK-293 cells transfected with TRPC5 are sensitive to constitutively active G␣ s , and to activation of ␤ 2 -adrenergic receptors, which also activate G␣ s . Downstream of G␣ s , AC was observed to regulate TRPC5 conductance, as activators of AC (FSK and 8-Br-cAMP) also inhibited cesium-induced currents (Fig. 3) . Conversely, the PKA inhibitors H-89 and KT-5720 blocked the inhibitory effects of ISO, FSK, 8-Br-cAMP, and G␣ s on TRPC5 currents (Fig. 4) . In addition, we have shown that this inhibition by PKA is mediated by phosphorylation at residues S796 and S794 on TRPC5. Our data lead us to believe that S796 is the primary site required for this regulation (Fig. 5) . Imaging by confocal microscopy and surface biotinylation of TPRC5 indicated that changes to the synthesis or surface expression of TRPC5 as a result of prolonged G␣ s (Q227L) exposure are unlikely to account for these effects (Fig. 6) . In murine intestinal smooth muscle cells, 8-Br-cAMP, adrenaline, and ISO decreased the nonselective cation current activated by GTP␥S or carbachol (Fig. 7) .
Multiple TRPC5 channel populations are likely to be maintained on the cell membrane based on whole cell patch-clamp recordings, including possibly constitutively Fig. 5 . PKA phosphorylation of TRPC5 mutant and the effect of G␣s (Q227L) on various transient receptor potential channels. A: inward currents at Ϫ60 mV are summarized. The ratio of inhibition is affected by the mutation site. S796 is the most effective phosphorylation site by PKA. B: I-V relationships showed a typical doubly rectifying shape. C: summary of inward currents at Ϫ60 mV. Coexpressed G␣s (Q227L) did not inhibit TRPC6 or transient receptor potential vanilloid 6 (TRPV6), but inhibited TRPC5 and TRPC4. The inhibition of TRPC5 and TRPC4 by PKA was specific. WT, wild type. **P Ͻ 0.01. *P Ͻ 0.05. active TRPC5 and TRPC5 activated by GTP␥S (29) . This may affect the ability to resolve the effects of cAMP/PKA on TRPC5 function. In addition, variability may be due to variable cAMP production by endogenous AC. Based on our observations, the main reason seems to be the difference of the concentration. In the context of AC, FSK appeared to be the more potent one used in this study, based on the fact that 10 M 8-Br-cAMP did not affect TRPC5 conductance (Supplemental Fig. S2 ), whereas the same FSK concentration partially inhibited TRPC5. It is not clear how FSK would inhibit function only partially at this concentration. It is possible that protein phosphatase might be involved in the regulation of TRPC5 by PKA. Indeed, when we included protein phosphatase inhibitor in the patch pipette solution, the degree of inhibition increased (Supplemental Fig. S6) . To activate TRPC5, we used GTP␥S, i.e., GTP␥S within the patch pipette solution. After breaking the cell membrane, GTP␥S diffused into cytosol and bound to and activated G proteins. Based on our experimental results, we assume that GTP␥S first activates the G proteins, G␣ i/o proteins, required for TRPC5 activation, although we do not know why GTP␥S first activates G␣ i/o protein rather than G␣ s protein.
When ISO was applied to the cell, ISO activates G␣ s subunit efficiently at this time, and GTP␥S can bind. As a possible explanation, the G␣ i/o protein seems to bind directly with TRPC5 channels without any receptor stimulation, whereas G␣ s is activated when the receptor is stimulated. The effect of G␣ i/o proteins on the activation of TRPC5 channels needs future studies.
While we examined the surface expression with biotinylation method, we found that G␣ s (Q227L) increased surface expression of TRPC5, although such an effect did not explain the effect of G␣ s (Q227L) on TRPC5. This result is contradictory to our expectation of inhibited synthesis or surface expression by cAMP pathway. cAMP/PKA pathway is involved in the activation of TPRC3 and TRPC6 channels in renal epithelial cells. AVP stimulation of V2 receptors causes translocation of TRPC3 to the apical membrane via stimulation of the AC/cAMP/PKA signaling cascade (11) . Recently in HEK cells, cAMP activates TRPC6 via PI3K-PKB-MEK-ERK1/2 signaling pathway. In glomerular mesangial cells, glucagon-induced intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) rises are also mediated through cAMP-PI3K-PKB-MEK-ERK1/2-TRPC6 signaling pathway (30) . In our hands, we used GTP␥S within the pipette to activate TRPC5, which might activate the above pathway after the rupture of the cell membrane before the treatment of 8-Br-cAMP. Consequently, we might observe only the inhibitory effect of cAMP on TRPC5 via direct phosphorylation. Further studies about whether the signaling pathways exist in native visceral tissues, whether cAMP increases [Ca 2ϩ ] i by activating IP 3 receptor (40) and finally activates TRPC5 (3, 16, 26, 38, 42) , or whether Epac explains various effects of cAMP that cannot be attributed to the established targets PKA (10) , are needed in the future. Until now, the G␣ q -PLC pathway was the only apparent activation pathway for TRPC4 and TRPC5 channels. The exact activation mechanism of TRPC5 by PLC was not evidenced. However, phosphatidylinositol 4,5-bisphosphate was suggested to be involved in the activation process of TRPC5 (15, 27, 36) . Another activator for the TRPC4 channel, G␣ i2 protein, has been described (12) . On the other hand, PKC is a molecule involved in the desensitization process, and the G␣ q -PLC-PKC pathway is known to control phosphorylation of mouse TRPC5 at Thr-972 (22, 25, 44) . In this study, we describe the G␣ s -cAMP-PKA pathway as a regulator of TRPC5 and TRPC4.
In Drosophila, the trpl ion channel has two very different calmodulin-binding sites, CBS-1 and CBS-2. CBS-2 may be involved in gating the channel in response to changing intracellular Ca 2ϩ /calmodulin levels, whereas CBS-1 may modulate this gating by providing an alternative binding site for calmodulin under specific Ca 2ϩ concentration and phosphorylation conditions (39) . The effect of phosphorylation of CBS-1 by PKA suggests a mechanism for modulation of channel activity. Phosphorylation at this serine caused CBS-1 to lose its affinity for Ca 2ϩ /calmodulin, which would prevent calmodulin from moving to CBS-1, thereby leaving it bound at CBS-2 and keeping the channel closed (33) . The effect of phosphorylation of CBS-1 by PKC is not as clear. No effect on calmodulin binding was observed, but, when both kinases were used to phosphorylate CBS-1, it was observed that phosphorylation by PKC resulted in a significant reduction in phosphorylation by PKA. Phosphorylation of CBS-1 by PKC in vivo may, therefore, regulate the phosphorylation of CBS-1 by PKA, thus affecting its modulation of channel activity (39) . TRPC5 has also two CaM binding site, CBS-1 (701-733; also called CIRB) and CBS-2 (822-860; CBII) (26) , and the other putative PKA phosphorylation sites (S821, S841), as well as S794 and S796, are located within or near CBS-2. This example of indirect regulation by phosphorylation in Drosophila could mirror what we present for TRPC5. TRPC4 and TRPC5 exhibit properties similar to Ca 2ϩ -permeable nonselective cation channels (NSCCs) activated by muscarinic stimulation in visceral smooth muscles (14, 20, 21, 44, 45) and neuronal cells (5, 23, 34) . In visceral smooth muscles, NSCCs activated by muscarinic stimulation were blocked by anti-G␣ i/o antibodies, but not by anti-G q antibodies (18, 41) . Among G␣ proteins, G␣ i2 selectively activated TRPC4␤, but not TRPC5, TRPC6, or TRPV6 when they were expressed in HEK cells. Among various G␣ proteins, only the constitutively active form of G␣ i2 activated TRPC4␤. On the other hand, constitutively active G␣ i2 did not activate TRPC5, TRPC6, or TRPV6 (12) . In gastric guinea pig myocytes, NSCCs were activated by muscarinic stimulation. Desensitization of this channel was found to depend on PKC activity (17) , to be dependent on [Ca 2ϩ ] i , and to be reversed by PKC inhibitors. It was previously shown that TRPC5 and TRPC4 are molecular candidates for the NSCC that is activated by muscarinic stimulation in murine gastric myocytes (14, 20, 21, 44, 45) . The desensitization of TRPC5 might correspond to the desensitization of the NSCCs activated by muscarinic stimulation in native tissues, such as in the gastric myocytes of guinea pigs and murine gastric myocytes. However, there has not yet been a report on the effect of PKA on the NSCC that is activated by muscarinic stimulation. In this study, pretreatment with cell-permeable 8-Br-cAMP did not have any effect at lower concentrations, but, at relatively high concentration, it inhibited the inward currents (Fig. 3) . Recently, Tsvilovskyy et al. (37) showed that TRPC6, as well as TRPC4, contributes smooth muscle contraction and intestinal motility in vivo. Considering that the cAMP-PKA pathway did not affect TRPC6, the inhibitory effect of the cAMP-PKA pathway on carbachol-induced currents must be via its overall effect on TRPC4␤, in addition to minor effects on TRPC4␣ or TRPC5.
We show that TRPC5 channels may become directly phosphorylated by PKA at serine residues 794 and 796, and that this phosphorylation abolishes the receptor-operated nonselective cation current mediated by TRPC5 channels in HEK-293 cells. Considering the similar inhibitory effect on TRPC4 but not TRPC6, this mechanism may be physiologically important in visceral tissues, where muscarinic receptor and ␤ 2 -adrenergic receptor are involved in the relaxation and contraction of smooth muscles.
